Effect of home-based pulmonary rehabilitation in patients with interstitial lung disease in a tertiary care centre – a stratified randomized controlled trial
Keywords:
Interstitial lung disease, Pulmonary rehabilitation, 6-Minute walk test, rct, k-bildAbstract
Background and aim:
Interstitial lung disease causes functional limitation and exercise intolerance. Although pulmonary rehabilitation in ILD can improve physical function and quality of life, multiple factors hinder its utilisation including lack of facilities, mobility, caregivers and cost. Therefore, alternative models such as home-based pulmonary rehabilitation are required to bridge the gap between guidelines and practice. We explored whether a 12-week home-based pulmonary rehabilitation program could improve the functional capacity of ILD patients as measured by 6MWD when compared to conventional drug therapy alone.
Methods:
Patients suffering from ILD attending a tertiary hospital in South-India were stratified according to disease sub-type and randomised. A structured 12-weeks home-based pulmonary rehabilitation consisting of exercise training, health education, nutritional and psychological support was provided to the intervention arm. Conventional drug therapy was continued in both arms. Change in 6MWD and FVC, K-BILD and HADS scores were measured at the end of 12 weeks. The results were analysed for determining factors responsible for the change in health status indicators.
Results:
At the end of 12 weeks, 6MWD and K-BILD scores alone showed statistically significant improvement in intervention arm when compared to controls. However, it did not reach the MCID for either parameter. Spirometry and HADS score had no significant improvement in either arm. Patients not provided pulmonary rehabilitation had an 81% reduction in the odds of improving their 6MWD and 86% reduction in odds of improving their K-BILD score at the end of 12 weeks. Those with lower baseline K-BILD scores were found to fare better with home-based pulmonary rehabilitation.
Conclusions
Home based pulmonary rehabilitation is an effective tool in improving 6MWD and K-BILD scores: measures of functional capacity and QoL respectively, among ILD patients irrespective of the ILD etiology, presence of pulmonary hypertension, LTOT requirement or duration to initiation of PR.
References
1. • Mendes RG, Castello-Simões V, Trimer R, et al. Exercise-based pulmonary rehabilitation for interstitial lung diseases: a review of components, prescription, efficacy, and safety. Front Rehabil Sci [Internet]. 2021;2. Available from: https://www.frontiersin.org/articles/10.3389/fresc.2021.744102
2. • Rochester CL, Alison JA, Carlin B, et al. Pulmonary rehabilitation for adults with chronic respiratory disease: an official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2023;208(4):e7-26. doi: 10.1164/rccm.202306-1066ST
3. • Cox NS, McDonald CF, Alison JA, et al. Telerehabilitation versus traditional centre-based pulmonary rehabilitation for people with chronic respiratory disease: protocol for a randomised controlled trial. BMC Pulm Med. 2018;18(1):71. doi: 10.1186/s12890-018-0646-0
4. • Choi HE, Kim TH, Jang JH, et al. The efficacy of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Life. 2023;13(2):2. doi: 10.3390/life13020403
5. • ATS Statement [INCOMPLETE]. Am J Respir Crit Care Med. 2002;166(1):111-7. doi: 10.1164/ajrccm.166.1.at1102
6. • Naz I, Sahin H, Demirci Uçsular F, Yalnız E. A comparison trial of eight weeks versus twelve weeks of exercise program in interstitial lung diseases. Sarcoidosis Vasc Diffuse Lung Dis Off J WASOG. 2018;35(4):299-307. doi: 10.36141/svdld.v35i4.6830
7. • Wallaert B, Duthoit L, Drumez E, et al. Long-term evaluation of home-based pulmonary rehabilitation in patients with fibrotic idiopathic interstitial pneumonias. ERJ Open Res. 2019;5(2):00045-2019. doi: 10.1183/23120541.00045-2019
8. • Matsuo S, Okamoto M, Ikeuchi T, et al. Early intervention of pulmonary rehabilitation for fibrotic interstitial lung disease is a favorable factor for short-term improvement in health-related quality of life. J Clin Med. 2021;10(14):3153. doi: 10.3390/jcm10143153
9. • Seleoglu I, Demirel A. Pulmonary rehabilitation in connective tissue disease-associated interstitial lung disease: a systematic review. Sarcoidosis Vasc Diffuse Lung Dis Off J WASOG. 2024;41(4):e2024061. doi: 10.36141/svdld.v41i4.15633
10. • du Bois RM, Weycker D, Albera C, et al. Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference. Am J Respir Crit Care Med. 2011;183(9):1231-7. doi: 10.1164/rccm.201007-1179OC
11. • El-Komy HM, Awad M, Mansour W, Elsayed EI. Impact of pulmonary rehabilitation on patients with interstitial lung diseases: an Egyptian experience. Egypt J Bronchol. 2019;13(2):2. doi: 10.4103/ejb.ejb_64_18
12. • Holland AE, Hill CJ, Glaspole I, Goh N, McDonald CF. Predictors of benefit following pulmonary rehabilitation for interstitial lung disease. Respir Med. 2012;106(3):429-35. doi: 10.1016/j.rmed.2011.11.014
13. • Devani P, Pinto N, Jain P, et al. Effect of pulmonary rehabilitation (PR) program in patients with interstitial lung disease (ILD)-Indian scenario. J Assoc Physicians India. 2019;67(3):28-33.
14. • Wu G, Sanderson B, Bittner V. The 6-minute walk test: how important is the learning effect? Am Heart J. 2003;146(1):129-33. doi: 10.1016/S0002-8703(03)00119-4
15. • Sinha A, Patel AS, Siegert RJ, et al. The King’s brief interstitial lung disease (KBILD) questionnaire: an updated minimal clinically important difference. BMJ Open Respir Res. 2019;6(1):e000363. doi: 10.1136/bmjresp-2018-000363
16. • Santos ES, Rodrigues G, Souto-Miranda S, et al. Anxiety and depression symptoms after pulmonary rehabilitation in people with interstitial lung disease: responders and non-responders. Eur Respir J. 2022;60(suppl 66). doi: 10.1183/13993003.congress-2022.3523
How to Cite
Issue
Section
License
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
